by
Lisa Chamoff, Contributing Reporter | October 29, 2018
From the October 2018 issue of HealthCare Business News magazine
Brainlab specializes in customized algorithms for the treatment site, working around the challenges of the spinal column.
In March 2017 Brainlab also released Elements Cranial SRS for treating primary tumors in the brain. The software corrects the cranial distortion from MR scans, Valcu said.
Ad Statistics
Times Displayed: 365889
Times Visited: 7102 Quality remanufactured Certified Centrifuges at Great prices! Fully warranted and backed by a company you can trust! Call or click for a free quote today! www.Centrifugestore.com 800-457-7576
“Planning automation is paramount for this software, starting with tools to correct MRI distortions and improve co-registration, to planning CT and continuing with a comprehensive risk organ definition based on a tissue-class universal atlas,” Valcu said.
The company plans to continue developing indication-specific solutions and plans to focus on metastases in the lung and liver and other body sites.
Elekta
Elekta has mainly been promoting its Elekta Unity MR-linac, which received a CE mark in June 2018 (the company submitted for FDA 510(k) clearance in beginning of August).
In August, the first treatment of a cancer patient with a recurrence in a pelvic lymph node with the Unity was completed in the Netherlands. The concentrated high-dose treatment took 10 days, significantly less than typical radiation therapy treatments that require up to 30 fractions, said Ioannis Panagiotelis, the chief Marketing and sales officer for Elekta.
On the software side, Elekta released a product called AQUA, which standardizes and automates clinical quality assurance tests.
The company also entered into two agreements. One is with IBM, to allow its Watson for Oncology to pair with Elekta’s MOSAIQ, oncology information system and personalize treatment with artificial intelligence (AI). Elekta also partnered with Palabra to allow clinicians to use voice commands for MOSAIQ to expedite clinical operations and reduce the time needed for data entry.
“Our customers have access to the latest and greatest when it comes to software solutions that have been developed by other parties,” Panagiotelis said.
RaySearch Laboratories
Late last year, RaySearch Laboratories released RayCare, its new oncology information system (OIS).
Johan Löf, president and chief executive officer of RaySearch Laboratories, said RayCare is a “completely new take on” the OIS, with an “advanced architecture that is extremely resilient and scalable.”
